{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:30:26Z","timestamp":1789381826965,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd006404","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000}}],"reference-count":81,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006404.pub2","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T14:04:36Z","timestamp":1393941876000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Artesunate plus pyronaridine for treating uncomplicated<i>Plasmodium falciparum<\/i>malaria"],"prefix":"10.1002","author":[{"given":"Hasifa","family":"Bukirwa","sequence":"first","affiliation":[{"name":"Makerere University Medical School; Mulago Hospital Complex PO Box 24943 Kampala Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Unnikrishnan","sequence":"additional","affiliation":[{"name":"Kasturba Medical College; Department of Community Medicine; Mangalore Karnataka India 575001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine V","family":"Kramer","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Cochrane Infectious Diseases Group; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Nair","sequence":"additional","affiliation":[{"name":"Kasturba Medical College; Community Medicine; Madhav Nagar D88A Ananthnagar Manipal Udupi India 576104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathap","family":"Tharyan","sequence":"additional","affiliation":[{"name":"Christian Medical College; South Asian Cochrane Network & Centre, Prof. BV Moses Centre for Evidence-Informed Health Care and Health Policy; Carman Block II Floor CMC Campus, Bagayam Vellore Tamil Nadu India 632002"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"10.1002\/14651858.CD006404.pub2-BIB0002|cit1","unstructured":"Kayentao K Pyronaridine-artesunate versus artemether\/lumefantrine: efficacy in malaria patients with uncomplicated acute falciparum malaria: results of a pivotal Phase III trial American Journal of Tropical Medicine and Hygiene 2008 114"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","article-title":"Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial","volume":"11","author":"Kayentao","year":"2012","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0003|cit3","unstructured":"NCT00541385 Pyronaridine\u00a0artesunate 3:1 granule formulation vs. Coartem\u00a9 crushed tablets in P.\u00a0falciparum \u00a0malaria pediatric patients www.clinicaltrials.gov\/show\/NCT00541385"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0005|cit4","unstructured":"Duparc S Borghini-Fuhrer I Craft JC Arbe-Barnes S Miller RM Shin CS Efficacy of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis American Journal of Tropical Medicine and Hygiene 2009 51 100"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0004|cit5","unstructured":"Duparc S Borghini-Fuhrer I Craft JC Arbe-Barnes S Miller RM Shin CS Safety of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis American Journal of Tropical Medicine and Hygiene 2009 101 150"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","article-title":"Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial","volume":"6","author":"Poravuth","year":"2011","journal-title":"PLoS One"},{"issue":"8993","key":"10.1002\/14651858.CD006404.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(96)91558-5","article-title":"Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa","volume":"347","author":"Ringwald","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/513942","article-title":"Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children","volume":"26","author":"Ringwald","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0009|cit9","unstructured":"NCT00403260 Pyronaridine\u00a0artesunate (3:1) versus mefloquine artesunate in P.\u00a0falciparum \u00a0malaria patients www.clinicaltrials.gov\/show\/NCT00403260"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0010|cit10","unstructured":"Rueangweerayut R Phyo AP Uchaisin C Poravuth Y Quang Binh T Tinto H A randomized clinical trial comparing the efficacy and safety of fixed-dose pyronaridine-artesunate versus mefloquine plus artesunate in uncomplicated Plasmodium falciparum malaria Submitted under review; personal communication by email from Isabelle Borghini Fuhrer, Medicines for Malaria Venture"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0011|cit11","unstructured":"Rueangweerayut R Phyo AP Uchaisin C Socheat D Quang Binh T Tinto H Efficacy and safety of pyronaridine\/artesunate fixed-dose combination compared with mefloquine plus artesunate in patients with acute uncomplicated Plasmodium falciparum malaria: results of a pivotal phase III trial Tropical Medicine and International Health 2009 30 97"},{"issue":"14","key":"10.1002\/14651858.CD006404.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Pyronaridine-artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD006404.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Supplement to: Pyronaridine-artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0014|cit14","unstructured":"Duparc S Borghini- Fuhrer I Craft JC Arbe- Barnes S Miller RM Shin CS Safety of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis American Journal of Tropical Medicine and Hygiene 2009 101 150"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0015|cit15","unstructured":"Duparc S Borghini-Fuhrer I Craft JC Arbe-Barnes S Miller RM Shin CS Efficacy of pyronaridine\/artesunate in clinical trials in patients with uncomplicated acute Plasmodium falciparum or Plasmodium vivax malaria: results of an integrated analysis American Journal of Tropical Medicine and Hygiene 2009 51 100"},{"issue":"9724","key":"10.1002\/14651858.CD006404.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","article-title":"Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial","volume":"375","author":"Tshefu","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0017|cit17","first-page":"104","article-title":"Preliminary study of dihydroartemisinin\u00a0for treatment of falciparum malaria","volume":"7","author":"Cai","year":"1999","journal-title":"Journal of Practical Parasitic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0018|cit18","first-page":"104","article-title":"Analysis on the results of antimalarial pyronaridine combined with sulfadoxine and pyrimethamine to falciparum malaria","volume":"5","author":"Chang","year":"1997","journal-title":"Journal of Practical Parasitic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0019|cit19","first-page":"194","article-title":"Combined use of pyronaridine, sulfadoxine and primaquine in areas with chloroquine-resistant falciparum malaria","volume":"5","author":"Che","year":"1987","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0020|cit20","first-page":"24","article-title":"Efficacy of two combined therapies for treatment of chloroquine-resistant falciparum malaria","volume":"3","author":"Che","year":"1990","journal-title":"Chinese Journal of Parasitic Disease Control"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub2-BIB0021|cit21","first-page":"81","article-title":"Observation on the efficacy of combined use of some new antimalarials for the treatment of falciparum malaria in Hainan Province","volume":"7","author":"Chen","year":"1989","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0022|cit22","unstructured":"Fleckenstein L Ramharter M Kremsner PG Pharmacokinetics of pyronaridine: Artesunate (Pyramax \u00ae ) for treatment of children with acute uncomplicated Plasmodium falciparum malaria Tropical Medicine and International Health 2007 222"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0023|cit23","first-page":"285","article-title":"Effects of combined dose of pyronaridine\/sulfadoxine\/pyrimethamine on falciparum malaria","volume":"6","author":"Huang","year":"1988","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0024|cit24","first-page":"19","article-title":"Therapeutic effect of pyronaridine in plain tablets and enteric coated tablets in falciparum malaria patients","volume":"7","author":"Huang","year":"1989","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006404.pub2-BIB0025|cit25","first-page":"175","article-title":"Comparison of different regimen of pyronaridine and sulfadoxine combined with pyrimethamine in the treatment of malignant malaria","volume":"11","author":"Huang","year":"1993","journal-title":"Chinese Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0026|cit26","first-page":"314","article-title":"Comparative studies on the treatment of drug-resistant falciparum malaria with single-dose or two-day regimens of pyronaridine\/sulfadoxine-pyrimethamine plus primaquine","volume":"14","author":"Haung","year":"1996","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0027|cit27","first-page":"193","article-title":"Study on Treatment of Multi-drug resistant Falciparum Malaria by Using a Combination of Dihydroartemisinin and Pyronaridine","volume":"20","author":"Liu","year":"2002","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi [Chinese Journal of Parasitology and Parasitic Diseases]"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1996.54.205","article-title":"Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0029|cit29","unstructured":"Looareesuwan S Gaye O Tjitra E Bojang K Socheat D Piola P Results of a randomized, multicentre, phase II, dose-ranging, clinical study to assess the safety and efficacy of fixed dose, orally administered pyronaridine and artesunate in adult patients with acute uncomplicated Plasmodium falciparum malaria Abstracts of the 56th Annual Meeting of the American Society of Tropical Medicine and Hygiene 2007 287"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0030|cit30","unstructured":"NCT01156389 Pyronaridine\/Artesunate-Ritonavir drug drug interaction study www.clinicaltrials.gov\/show\/ NCT01156389"},{"issue":"11","key":"10.1002\/14651858.CD006404.pub2-BIB0031|cit31","first-page":"646-7, 700","article-title":"Efficacy of pyronaridine in 510 acute malaria cases","volume":"24","author":"No authors","year":"1985","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0032|cit32","first-page":"167","article-title":"Efficacy of combined use of various preparations of pyronaridine, sulfadoxine and pyrimethamine in the treatment of falciparum malaria","volume":"2","author":"Pang","year":"1989","journal-title":"Chinese Journal of Parasitic Disease Control"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0033|cit33","unstructured":"Piola P Fleckenstein L Pharmacokinetics, clinical and safety outcomes of pyronaridine\/artesunate treatment of acute Plasmodium falciparum malaria in Uganda Abstracts of the 57th Annual meeting of the American Society of Tropical Medicine and Hygiene 2008 252"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0034|cit34","unstructured":"Piola P Fleckenstein L Pharmacokinetics, clinical and safety outcomes of pyronaridine\/artesunate treatment of acute Plasmodium falciparum malaria in Uganda American Journal of Tropical Medicine and Hygiene 2008 195"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1086\/591096","article-title":"Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon","volume":"198","author":"Ramharter","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0036|cit36","first-page":"65","article-title":"A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine\/sulfadoxine\/pyrimethamine in Diaoluo area, Hainan Province","volume":"22","author":"Shao","year":"1991","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0037|cit37","unstructured":"Tan B Fleckenstein lL Yu KS Jang IJ Population pharmacokinetics of artesunate and dihydroartemisinin in healthy volunteers American Journal of Tropical Medicine and Hygiene 2008 100 49"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0038|cit38","unstructured":"Wattanavijitkul T Fleckenstein L Yu KS Jang IJ Multiple-dose population pharmacokinetics of pyronaridine in healthy volunteers American Journal of Tropical Medicine and Hygiene 2008 250 99"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/AAC.00119-06","article-title":"Targeting of hematin by the antimalarial pyronaridine","volume":"50","author":"Auparakkitanon","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD006404.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/00034983.1992.11812693","article-title":"In vitro activity of pyronaridine against African strains of Plasmodium falciparum","volume":"86","author":"Basco","year":"1992","journal-title":"Annals of Tropical Medicine and Parasitology"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0041|cit41","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria [WHO\/HTM\/RBM\/2003.50]","author":"Bloland","year":"2003"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0042|cit42","first-page":"73","article-title":"In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Cote d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine","volume":"12","author":"Brice","year":"2010","journal-title":"Tanzanian Journal of Health Research"},{"issue":"2","key":"10.1002\/14651858.CD006404.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2003.68.133","article-title":"Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp","volume":"68","author":"Cattamanchi","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1383-5769(99)00028-8","article-title":"Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro","volume":"48","author":"Chavalitshewinkoon-Petmitr","year":"2000","journal-title":"Parasitology International"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(92)90414-8","article-title":"Studies on a new antimalarial compound: pyronaridine","volume":"86","author":"Chang","year":"1992","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006404.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.1988.38.24","article-title":"In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum","volume":"38","author":"Childs","year":"1988","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0047|cit47","first-page":"270","article-title":"Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC,\u00a0Shin\u00a0CS, Fleckenstein L, et al","volume":"11","author":"Review of\u00a0pyronaridine\u00a0anti-malarial","year":"2010","journal-title":"Malaria Journal"},{"issue":"4","key":"10.1002\/14651858.CD006404.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nature Reviews Microbiology"},{"issue":"70","key":"10.1002\/14651858.CD006404.pub2-BIB0049|cit49","first-page":"Epub 2013\/02\/26","article-title":"Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials","volume":"12","author":"Duparc","year":"2013","journal-title":"Malaria journal"},{"issue":"11","key":"10.1002\/14651858.CD006404.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0169-4758(91)90267-R","article-title":"Pyronaridine: a new antimalarial drug","volume":"7","author":"Fu","year":"1991","journal-title":"Parasitology Today"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0051|cit51","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"issue":"7651","key":"10.1002\/14651858.CD006404.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0053|cit53","unstructured":"Higgins JPT Green S (editors) Appendix 5b: Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. In: Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.5 [updated May 2005]. The Cochrane Collaboration, 2005 Available from www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0054|cit54","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7303","key":"10.1002\/14651858.CD006404.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2875-8-79","article-title":"In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays","volume":"8","author":"Kurth","year":"2009","journal-title":"Malaria Journal"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/17512433.1.6.745","article-title":"Importance of the long-acting partner drug in artemisinin-based combination therapy","volume":"1","author":"Kurtzhals","year":"2008","journal-title":"Expert Reviews in Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006404.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/AAC.01304-09","article-title":"Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007","volume":"54","author":"Lim","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0059|cit59","unstructured":"Chandler J Churchill R Higgins J Lasserson T Tovey D Methodological Expectations of Cochrane Intervention Reviews (MECIR) Methodological standards for the conduct of new Cochrane Intervention Reviews. Version 2.1, 8 December 2011. Available at: http:\/\/www.editorial-unit.cochrane.org\/sites\/editorial-unit.cochrane.org\/files\/uploads\/MECIR_conduct_standards%202.1.pdf"},{"issue":"12","key":"10.1002\/14651858.CD006404.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/tx980148k","article-title":"Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs","volume":"11","author":"Naisbitt","year":"1998","journal-title":"Chemical Research in Toxicology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD006404.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Pradines B Tall A Parzy D Spiegel A Fusai T Hienne R In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents Journal of Antimicrobial Chemotherapy 1998 333 9","DOI":"10.1093\/jac\/42.3.333"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-9-339","article-title":"Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum","volume":"9","author":"Pradines","year":"2010","journal-title":"Malaria Journal"},{"issue":"12","key":"10.1002\/14651858.CD006404.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/AAC.00801-10","article-title":"In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax","volume":"54","author":"Price","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub2-BIB0065|cit65","first-page":"544","article-title":"Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance","volume":"23","author":"Qi","year":"2002","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0066|cit66","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"6","key":"10.1002\/14651858.CD006404.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/AAC.43.6.1525","article-title":"In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum","volume":"43","author":"Ringwald","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD006404.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/AAC.42.9.2410","article-title":"Effect of disposition of mannich antimalarial agents on their pharmacology and toxicity","volume":"42","author":"Ruscoe","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0069|cit69","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org 2008","DOI":"10.1002\/9780470712184.ch12"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007483.pub2","article-title":"Artemisinin-based combination therapy for treating uncomplicated malaria","author":"Sinclair","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actatropica.2007.12.005","article-title":"Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo","volume":"105","author":"Vivas","year":"2008","journal-title":"Acta Tropica"},{"issue":"10","key":"10.1002\/14651858.CD006404.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0169-4758(96)10055-7","article-title":"Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria","volume":"12","author":"White","year":"1996","journal-title":"Parasitology Today"},{"issue":"9168","key":"10.1002\/14651858.CD006404.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(98)07367-X","article-title":"Averting a malaria disaster","volume":"353","author":"White","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD006404.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1471-4922(02)02373-5","article-title":"The assessment of antimalarial drug efficacy","volume":"18","author":"White","year":"2002","journal-title":"Trends in Parasitology"},{"issue":"8","key":"10.1002\/14651858.CD006404.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0076|cit76","unstructured":"World Health Organization Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations http:\/\/whqlibdoc.who.int\/publications\/2008\/9789241596305_eng.pdf"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0077|cit77","unstructured":"World Health Organization Malaria treatment guidelines - 2nd edition www.who.int\/malaria\/publications\/atoz\/9789241547925\/en\/index.html"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0078|cit78","unstructured":"World Health Organization Global report on antimalarial drug efficacy and drug resistance 2000-2010 www.who.int\/malaria\/publications\/atoz\/9789241500470\/en\/index.html"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0079|cit79","unstructured":"World Health Organization Global plan for artemisinin resistance containment (GPARC) www.who.int\/malaria\/publications\/atoz\/9789241500838\/en\/index.html"},{"key":"10.1002\/14651858.CD006404.pub2-BIB0080|cit80","article-title":"World Malaria Report 2012","volume-title":"World Malaria Report 2012","author":"WHO Global Malaria Programme","year":"2012"},{"issue":"3","key":"10.1002\/14651858.CD006404.pub2-BIB0081|cit81","first-page":"460","article-title":"In vitro sensitivity of Plasmodium falciparum to eight antimalarials in China-Myanmar and China-Lao PDR border areas","volume":"28","author":"Yang","year":"1997","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006404.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006404.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T19:48:38Z","timestamp":1716580118000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006404.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006404.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006404.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,4]]}}}